Amferia AB is a Swedish AB based in Mölndal, operating in the Manufacture of medical and dental instruments and supplies sector. Incorporated in 2018, the company reported revenue of 34,3 tn kr in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska tillhandahålla medicintekniskt material för behandling samt för förebyggande av bakteriella infektioner.
In its most recent annual report (2025), Amferia AB reported revenue of 34,3 tn kr, a decrease of 99% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of 15,5 mn kr, and the EBITDA margin stood at -41,244.2%.
At the end of 2025, equity financed 93.2% of the balance sheet, and current assets covered short-term debt 14.4 times.
Frequently asked questions
What is the Org number of Amferia AB?
Amferia AB is registered with Bolagsverket / SCB under Org 5591701262.
What is the revenue of Amferia AB?
Amferia AB reported revenue of 34,3 tn kr in 2025.
Who is the CEO of Amferia AB?
Anand Kumar Rajasekharan is the CEO of Amferia AB, in role since 2020.
Who is the chairman of Amferia AB?
Eva Agneta Edberg chairs the board of Amferia AB, in role since 2022.
Where is Amferia AB headquartered?
Amferia AB's registered address is Az Bioventurehub Astrazeneca.
